Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

被引：3
|
作者：
Pathak, Vivek [1 ]
Venkatesan, Madhav [1 ]
Regunathan-Shenk, Renu [1 ,2 ]
机构：
[1] Kovai Med Ctr & Hosp, Nephrol, Coimbatore 641014, Tamil Nadu, India
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 02期
关键词：
clinical nephrology; cyclosporine; membranous glomerulonephritis; remission induction; rituximab; tacrolimus;
D O I：
10.34067/KID.0004672020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy A meta-analysis
    Gong, Lifeng
    Xu, Min
    Xu, Wei
    Tang, Weigang
    Lu, Jingkui
    Jiang, Wei
    Xie, Fengyan
    Ding, Liping
    Qian, Xiaoli
    MEDICINE, 2021, 100 (51)
  • [32] CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
    Ramachandran, Raja
    Yadav, Ashok K.
    Kumar, Vinod
    Gupta, Krishan L.
    Kohli, Harbir S.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01): : 89 - 90
  • [33] New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy
    Shao, Lina
    Jin, Juan
    Ye, Binxian
    Xu, Baihui
    Li, Yiwen
    Gong, Jianguang
    Zhang, Jiong
    Chen, Maosheng
    He, Qiang
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (06): : 1352 - 1362
  • [34] A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy
    Boumpas, DT
    Tassiulas, IO
    Fleisher, TA
    Vaughan, E
    Piscitelli, S
    Kim, Y
    Pucino, F
    Balow, JE
    Austin, HA
    CLINICAL NEPHROLOGY, 1999, 52 (02) : 67 - 75
  • [35] Tacrolimus and low-dose prednisolone combination therapy is a promising regimen in resistant or relapsing primary glomerulonephritis
    Arikan, Hakki
    Koc, Mehmet
    Cakalagaoglu, Fulya
    Tuglular, Serhan
    Ozener, Cetin
    Akoglu, Emel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 64 - 64
  • [36] A CASE OF SEVERE MEMBRANOUS NEPHROPATHY AFTER MRNA COVID-19 VACCINATION TREATED WITH COMBINATION RITUXIMAB AND TACROLIMUS
    Radford, Lorna
    Puri, Prianka
    NEPHROLOGY, 2022, 27 : 82 - 82
  • [37] Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
    Shang, Shunlai
    Cui, Shaoyuan
    Wang, Wenjuan
    Wang, Chao
    Li, Ping
    Li, Wenge
    Li, Qinggang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
    Gao, Shuang
    Cui, Zhao
    Wang, Xin
    Zhang, Yi-miao
    Wang, Fang
    Cheng, Xu-yang
    Meng, Li-qiang
    Zhou, Fu-de
    Liu, Gang
    Zhao, Ming-hui
    FRONTIERS IN MEDICINE, 2021, 8
  • [39] EFFICACY OF LOW OR STANDARD DOSE RITUXIMAB AS COMPARED TO PONTICELLI'S REGIMEN IN MEMBRANOUS NEPHROPATHY
    Roccatello, Dario
    Fenoglio, Roberta
    Sciascia, Savino
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [40] Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
    Hu, Xiaofan
    Zhang, Muyin
    Xu, Jing
    Gao, Chenni
    Yu, Xialian
    Li, Xiao
    Ren, Hong
    Wang, Weiming
    Xie, Jingyuan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (12): : 1594 - 1602
12345